FKBP9 Enhances Colon Cancer Cell Proliferation by Inhibiting GPX4 ‐Mediated Ferroptosis
Open Access
- 27 May 2026
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 15 (6) , e71772
Abstract
Colorectal cancer, a major health issue worldwide, exhibits intricate molecular mechanisms that necessitate further exploration, particularly regarding regulated cell death pathways, such as ferroptosis. This study investigated the role of the immunophilin FKBP9 (FK506 Binding Protein 9) in colon cancer, specifically its effects on cell proliferation and ferroptosis resistance. Using molecular biology techniques, including quantitative reverse transcription PCR, Western blotting, and cell proliferation assays, we established that FKBP9 is overexpressed in colon cancer cell lines HCT116 and SW480. Furthermore, we demonstrated that FKBP9 enhances cell proliferation by inhibiting ferroptosis through glutathione peroxidase 4 (GPX4) expression upregulation, thereby reducing reactive oxygen species levels and stabilizing GPX4 by preventing its autophagic degradation. Notably, increased FKBP9 expression is associated with lower overall survival rates in patients with colon cancer, suggesting its potential as a prognostic marker. These findings underscore the therapeutic potential of FKBP9 in colon cancer, offering a new method to sensitize cancer cells to ferroptosis and improve patient outcomes.Keywords
This publication has 21 references indexed in Scilit:
- USP31 confers radio-resistance in cervical cancer cells via ferroptosis pathway by deubiquitinating and stabilizing GPX4Biochemical and Biophysical Research Communications, 2025
- FADS2 inhibits colorectal cancer cell proliferation by regulating ferroptosis through SLC7A11/GPX4Molecular Biology Reports, 2025
- Factors associated with diagnostic and treatment intervals in colorectal cancer: A linked data studyInternational Journal of Cancer, 2025
- The stability of FKBP9 maintained by BiP is crucial for glioma progressionGenes & Diseases, 2024
- Where do we stand with screening for colorectal cancer and advanced adenoma based on serum protein biomarkers? A systematic reviewMolecular Oncology, 2024
- Overall survival with non-proportional hazards in first-line treatment for patients with metastatic colorectal cancer: Systematic review and network meta-analysisHeliyon, 2024
- Astaxanthin ameliorates oxidative stress in lens epithelial cells by regulating GPX4 and ferroptosisChemico-Biological Interactions, 2023
- NKD1 targeting PCM1 regulates the therapeutic effects of homoharringtonine on colorectal cancerMolecular Biology Reports, 2023
- Identification of colon tumor marker NKD1 via integrated bioinformatics analysis and experimental validationCancer Medicine, 2021
- Increasing of FKBP9 can predict poor prognosis in patients with prostate cancerPathology - Research and Practice, 2020